Press Release

Gout Therapeutics Market to Grow with a CAGR of 8.74% through 2029

Growing adoption of biologics are expected to drive the Global Gout Therapeutics Market growth in the forecast period, 2025-2029.


According to TechSci Research report, “Gout Therapeutics Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, the Global Gout Therapeutics Market stood at USD 1.98 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 8.74% through 2029. The market's growth is driven by several key factors. These include the increasing adoption of biologics and heightened research and development efforts in regenerative medicines. Additionally, there's a rising prevalence of gout, fueled by escalating alcohol consumption. Technological advancements in imaging modalities have also played a significant role in enhancing our understanding of gout. Moreover, certain risk factors contribute to the development of gout. These encompass obesity, dietary habits, concurrent health conditions, and emerging connections between gout and other comorbidities like erectile dysfunction, atrial fibrillation, obstructive sleep apnea, osteoporosis, and venous thromboembolism.

According to the 2023 statistics released by the World Obesity Federation, it was noted that in 2020, 31.5% of men and 40.2% of women in Mexico were living with obesity. Similarly, based on a July 2021 Eurostat report, over half (53%) of Europeans were overweight in 2020, with 36% classified as pre-obese and 17% as obese. The report also highlights that the highest proportion of obese individuals was found among those aged 65 to 74 (66%), while the lowest was among the 18 to 24 age group (25%). The presence of a high body mass index (BMI) escalates the risk of developing gout by elevating serum uric acid levels, consequently leading to hyperuricemia, which inhibits renal urate secretion. This phenomenon is expected to drive the demand for effective treatments and therapeutics, subsequently fueling market growth.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Gout Therapeutics Market


The Global Gout Therapeutics Market is segmented into drug types, distribution channel and company.

In the Drug Type category, the segment focusing on Urate-lowering Drugs (ULDs) is poised to witness substantial market expansion throughout the forecast period. The Global Gout Therapeutics Market is anticipated to undergo significant growth, primarily propelled by the increasing significance of ULDs. These drugs, tailored to lower uric acid levels in the bloodstream, play a pivotal role in managing gout. The escalating prevalence of gout, coupled with the recognition of the crucial role of urate reduction in averting gout attacks, is propelling the demand for these medications. Healthcare providers are emphasizing the importance of maintaining stable uric acid levels for effective gout management, thus paving the way for market growth in Urate-lowering Drugs. Ongoing advancements in drug development, including the introduction of more potent and better-tolerated ULD formulations, are further contributing to the growing acceptance and utilization of these therapies.

Major companies operating in Global Gout Therapeutics Market are:

  • Abbott Laboratories Inc.
  • Medtronic Plc
  • Boston Scientific Corp
  • Becton, Dickinson and Company
  • Novartis AG
  • GlaxoSmithKline plc
  • Allergen, Inc.
  • W. L. Gore & Associates, Inc.
  • Stryker Corporation
  • Terumo Corporation


Download Free Sample Report

Customers can also request 10% free customization on this report


“This growth is primarily attributed to the increasing prevalence of gout and rising awareness among people about the disease treatment. Furthermore, the space has advanced and new therapeutic options with a robust drug pipeline are further accelerating the space growth. The strong research and development in the space have led to a robust product pipeline. Government agencies and private organizations strive to raise awareness through various awareness campaigns, further driving space growth. Furthermore, novel drugs in the space further boost the market growth. Moreover, the availability of investment in automating retail pharmacies to process pharmacy insurance information has contributed to the development of the retail supply chain. The technicians use medical billing and coding to modify medical information into billable codes leading to sustainable systems and driving segment growth.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.


Gout Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (NSAIDs, Colchicine, Urate-lowering Drugs, Biologics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, By Competition, 2019-2029F”, has evaluated the future growth potential of Global Gout Therapeutics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Gout Therapeutics Market.



TechSci Research LLC

420 Lexington Avenue,

Suite 300, New York,

United States- 10170

M: +13322586602

Email: [email protected]


Relevant News